Prophylactic treatments of opportunistic infections in acquired immunodeficiency syndrome
Longuet, P.; Leport, C.
Annales de Medecine Interne 143(1): 61-68
1992
ISSN/ISBN: 0003-410X PMID: 1534972 Document Number: 396424
Document emailed within 1 workday
Related Documents
De Graaff, C.S.; van der Meer, J.W.; Franken, C.; Kaajan, J.P. 1984: A patient with opportunistic infections due to acquired immunodeficiency syndrome Nederlands Tijdschrift Voor Geneeskunde 128(12): 549-553Pitchenik, A.E.; Fischl, M.A.; Dickinson, G.M.; Becker, D.M.; Fournier, A.M.; O'Connell, M.T.; Colton, R.M.; Spira, T.J. 1983: Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state Annals of Internal Medicine 98(3): 277-284
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to acquired immunodeficiency syndrome associated virus in sera from acquired immunodeficiency syndrome related complex and japanese hemophiliacs infected with acquired immunodeficiency syndrome associated virus Microbiology and Immunology 29(11): 1083-1088
Crumpacker, C.; Heagy, W.; Bubley, G.; Monroe, J.E.; Finberg, R.; Hussey, S.; Schnipper, L.; Lucey, D.; Lee, T.H.; McLane, M.F. 1987: Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation Annals of Internal Medicine 107(5): 664-674
DeRoux, S.J.; Adsay, N.V.; Ioachim, H.L. 1991: Disseminated pneumocystosis without pulmonary involvement during prophylactic aerosolized pentamidine therapy in a patient with the acquired immunodeficiency syndrome Archives of Pathology and Laboratory Medicine 115(11): 1137-1140
Borek, E.; Sharma, O.K.; Buschman, F.L.; Cohn, D.L.; Penley, K.A.; Judson, F.N.; Dobozin, B.S.; Horsburgh, C.R.; Kirkpatrick, C.H. 1986: Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome Cancer Research 46(5): 2557-2561
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Petitjean, J.; Quibriac, M.; Lechevalier, B.; Brouard, J.; Freymuth, F. 1988: Respiratory Mycoplasma pneumoniae infections in the acquired immunodeficiency syndrome Presse Medicale 17(34): 1762
Masukawa, I.I.; Barone, A.A. 1996: Bacterial infections in patients with acquired immunodeficiency syndrome (AIDS). Review of literature Revista do Hospital das Clinicas 51(1): 26-33
Demonty, J. 1993: Opportunistic infections in advanced immunodeficiency Revue Medicale de Liege 48(2): 83-91
Erlich, K.S.; Jacobson, M.A.; Koehler, J.E.; Follansbee, S.E.; Drennan, D.P.; Gooze, L.; Safrin, S.; Mills, J. 1989: Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial Annals of Internal Medicine 110(9): 710-713
Vieira, J.; Frank, E.; Spira, T.J.; Landesman, S.H. 1983: Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants New England Journal of Medicine 308(3): 125-129
Khan, M.S.; Unemo, M.; Zaman, S.; Lundborg, C.S.ål. 2009: Knowledge, attitudes and practices regarding human immunodeficiency virus/acquired immune deficiency syndrome and sexually transmitted infections among health care providers in Lahore, Pakistan Journal of Ayub Medical College Abbottabad: Jamc 21(4): 1-6
Villanueva, J.L.; Prada, J.L.; Kindelán, J.M.; Torre-Cisneros, J. 1994: CD4+ lymphocytes and opportunistic infections and neoplasms in patients infected with the human immunodeficiency virus Medicina Clinica 103(19): 758-759
Seligmann, M.; Pinching, A.J.; Rosen, F.S.; Fahey, J.L.; Khaitov, R.M.; Klatzmann, D.; Koenig, S.; Luo, N.; Ngu, J.; Riethmüller, G. 1987: Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update Annals of Internal Medicine 107(2): 234-242
Ioachim, H.L. 1990: Biopsy diagnosis in human immunodeficiency virus infection and acquired immunodeficiency syndrome Archives of Pathology and Laboratory Medicine 114(3): 284-294
Strawford, A.; Hellerstein, M. 1998: The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome Seminars in Oncology 25(2 Suppl 6: 76-81
Appel, G.B.; Nicolaides, M.N. 1991: Human immunodeficiency virus/acquired immunodeficiency syndrome nephropathy in the inner city New York State Journal of Medicine 91(5): 207-210
Kaplan, J.E.; Hu, D.J.; Holmes, K.K.; Jaffe, H.W.; Masur, H.; De Cock, K.M. 1996: Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world American Journal of Tropical Medicine and Hygiene 55(1): 1-11
Kalaajieh WK 2000: Epidemiology of human immunodeficiency virus and acquired immunodeficiency syndrome in Lebanon from 1984 through 1998 International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(4): 209-213